Patrick P. Gleason
Impact in
- Family Practice top 2%
- Medication Adherence and Compliance
Papers in
-
- Medication Adherence and Compliance 9
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 4
- Economic and Financial Impacts of Cancer 4
- Co-authors
- Michael J. Fine (3 shared papers)Deron Galusha (1 shared paper)Jonathan M. Fine (1 shared paper)Thomas P. Meehan (1 shared paper)Catherine I. Starner (14 shared papers)Jeremy A Schafer (6 shared papers)Alan Heaton (6 shared papers)Brent W. Gunderson (5 shared papers)
- Journals
- Journal of Managed Care & Specialty Pharmacy (10 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (7 papers)Journal of Clinical Oncology (3 papers)American Journal of Health-System Pharmacy (2 papers)Journal of General Internal Medicine (2 papers)
- Partner nations
- United StatesNew ZealandFrance
In The Last Decade
Patrick P. Gleason
47 papers receiving 1.4k citations
Patrick P. Gleason's Hit Papers
Peers
Comparison fields: 5 of 98
- Family Practice 83
- Applied Microbiology and Biotechnology 67
- Critical Care and Intensive Care Medicine 122
- Geriatrics and Gerontology 59
- Epidemiology 529
Countries citing papers authored by Patrick P. Gleason
This map shows the geographic impact of Patrick P. Gleason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick P. Gleason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick P. Gleason more than expected).
Fields of papers citing papers by Patrick P. Gleason
This network shows the impact of papers produced by Patrick P. Gleason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick P. Gleason. The network helps show where Patrick P. Gleason may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick P. Gleason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 378 | |
| 2 | 1997 | 185 | |
| 3 | 1998 | 88 | |
| 4 | 2008 | 84 | |
| 5 | 1998 | 82 | |
| 6 | Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes Hit paper breakdown → | 2024 | 80 |
| 7 | 2009 | 70 | |
| 8 | 2001 | 60 | |
| 9 | 2014 | 44 | |
| 10 | 2013 | 42 | |
| 11 | 2007 | 29 | |
| 12 | 2009 | 28 | |
| 13 | 1997 | 23 | |
| 14 | 2002 | 20 | |
| 15 | 2013 | 19 | |
| 16 | 2012 | 18 | |
| 17 | 2005 | 17 | |
| 18 | 2009 | 17 | |
| 19 | 2009 | 17 | |
| 20 | 2005 | 16 |
About Patrick P. Gleason
Patrick P. Gleason is a scholar working on Family Practice, Economics and Econometrics, Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine, having authored 50 papers that have together received 1.5k indexed citations. Recurring topics across this work include Medication Adherence and Compliance (9 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (4 papers), Economic and Financial Impacts of Cancer (4 papers), Pneumonia and Respiratory Infections (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Diabetes Treatment and Management (2 papers) and Schizophrenia research and treatment (2 papers). The work is most often cited by research in Family Practice (83 citations), Applied Microbiology and Biotechnology (67 citations), Critical Care and Intensive Care Medicine (122 citations), Geriatrics and Gerontology (59 citations) and Epidemiology (529 citations). Patrick P. Gleason has collaborated with scholars based in United States, New Zealand and France. Frequent co-authors include Michael J. Fine, Deron Galusha, Jonathan M. Fine, Thomas P. Meehan, Catherine I. Starner, Jeremy A Schafer, Alan Heaton, Brent W. Gunderson, Yang Qiu and Soma Sen. Their work appears in journals such as Journal of Managed Care & Specialty Pharmacy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of Clinical Oncology, American Journal of Health-System Pharmacy and Journal of General Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.